Skip Navigation



eCAM Advance Access published online on January 28, 2005
eCAM, doi:10.1093/ecam/neh058
This Article
Right arrow Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
2/1/59    most recent
neh058v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Hajtó, T.
Right arrow Articles by Németh, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hajtó, T.
Right arrow Articles by Németh, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2005). Published by Oxford University Press. All rights reserved.
Received October 1, 2004
Revised November 11, 2004
Accepted December 24, 2004

Review

Oncopharmacological Perspectives of a Plant Lectin (Viscum album Agglutinin-I): Overview of Recent Results from In vitro Experiments and In vivo Animal Models, and Their Possible Relevance for Clinical Applications

Tibor Hajtó 1, Katarina Hostanska 2, Timea Berki 1, László Pálinkás 1, Ferenc Boldizsár 1, and Péter Németh 1*

1 Department of Immunology and Biotechnology, University of Pécs, Faculty of Medicine, Pécs, Hungary
2 Department of Internal Medicine, University Hospital Zürich, Switzerland

* To whom correspondence should be addressed.
Péter Németh, E-mail: peter.nemeth{at}aok.pte.hu



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Evid Based Complement Alternat MedHome page
V. Ramnath, P. S. Rekha, G. Kuttan, and R. Kuttan
Regulation of Caspase-3 and Bcl-2 Expression in Dalton's Lymphoma Ascites Cells by Abrin
Evid. Based Complement. Altern. Med., June 1, 2009; 6(2): 233 - 238.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
R. Ziegler
Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?
Evid. Based Complement. Altern. Med., March 1, 2009; 6(1): 19 - 30.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.